JAMIL KHURRAM (Chief Medical Officer) sold 60K shares of GALECTIN THERAPEUTICS INC on the open market
Open‑market sale worth $232.4K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 1/6/2026ACC: 0001133416-26-000004
Officer· Chief Medical Officer
Since Aug 2024
-60K
Net shares
Net seller
$232.4K
Total sold
3
Open market trades
0B · 3S
5
Total transactions
60K acquired · 120K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+60K
Price / share
—
Trade value
—
% of position
New position
1/2/2026
0.00→60K
Common Stock
Direct
Shares
−13.05K
Price / share
$4.20
Trade value
$54.79K
% of position
21.8%
1/2/2026
60K→46.95K
Common stock
Direct
Shares
−25.50K
Price / share
$3.90
Trade value
$99.41K
% of position
54.3%
1/5/2026
46.95K→21.45K
Common Stock
Direct
Shares
−21.45K
Price / share
$3.65
Trade value
$78.20K
% of position
New position
1/6/2026
21.45K→0.00
Total
Net shares
+0.00
Net value
-$232.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | M · Option Exercise | +60K | — | — | New position | 0.00 | 60K |
| Common Stock Direct | 1/2/2026 | S · Sale | −13.05K | $4.20 | $54.79K | 21.8% | 60K | 46.95K |
| Common stock Direct | 1/5/2026 | S · Sale | −25.50K | $3.90 | $99.41K | 54.3% | 46.95K | 21.45K |
| Common Stock Direct | 1/6/2026 | S · Sale | −21.45K | $3.65 | $78.20K | New position | 21.45K | 0.00 |
| Total | +0.00 | -$232.40K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
60K shares
Shares
−60K
Strike price
0
Held after
0.00
Exercisable
—
1/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock60K shares | 1/1/2026 | M · Option Exercise | −60K | 0 | — | 0.00 |